BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 36189588)

  • 1. Characterization of Mild Cognitive Impairment and Dementia among Community-Dwelling Mexican Americans and Non-Hispanic Whites.
    O'Bryant SE; Petersen M; Hall J; Johnson LA; Barber R; Phillips N; Braskie MN; Yaffe K; Rissman R; Toga A;
    J Alzheimers Dis; 2022; 90(2):905-915. PubMed ID: 36189588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic Profiles of Neurodegeneration Among Mexican Americans and Non-Hispanic Whites in the HABS-HD Study.
    O'Bryant SE; Zhang F; Petersen M; Hall JR; Johnson LA; Yaffe K; Braskie M; Vig R; Toga AW; Rissman RA;
    J Alzheimers Dis; 2022; 86(3):1243-1254. PubMed ID: 35180110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comorbid Depression and Diabetes as a Risk for Mild Cognitive Impairment and Alzheimer's Disease in Elderly Mexican Americans.
    Johnson LA; Gamboa A; Vintimilla R; Cheatwood AJ; Grant A; Trivedi A; Edwards M; Hall JR; O'Bryant SE
    J Alzheimers Dis; 2015; 47(1):129-36. PubMed ID: 26402761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A blood screening tool for detecting mild cognitive impairment and Alzheimer's disease among community-dwelling Mexican Americans and non-Hispanic Whites: A method for increasing representation of diverse populations in clinical research.
    O'Bryant SE; Zhang F; Petersen M; Hall JR; Johnson LA; Yaffe K; Mason D; Braskie M; Barber RA; Rissman RA; Mapstone M; Mielke MM; Toga AW;
    Alzheimers Dement; 2022 Jan; 18(1):77-87. PubMed ID: 34057802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of Mexican Americans with mild cognitive impairment and Alzheimer's disease.
    O'Bryant SE; Johnson L; Balldin V; Edwards M; Barber R; Williams B; Devous M; Cushings B; Knebl J; Hall J
    J Alzheimers Dis; 2013; 33(2):373-9. PubMed ID: 22976076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using Fractional Anisotropy Imaging to Detect Mild Cognitive Impairment and Alzheimer's Disease among Mexican Americans and Non-Hispanic Whites: A HABLE Study.
    Hall JR; Johnson LA; Zhang F; Petersen M; Toga AW; Shi Y; Mason D; Rissman RA; Yaffe K; O'Bryant SE;
    Dement Geriatr Cogn Disord; 2021; 50(3):266-273. PubMed ID: 34569492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Community-Based Study of Dementia in Mexican American and Non-Hispanic White Individuals.
    Morgenstern LB; Briceño EM; Mehdipanah R; Chang W; Lewandowski-Romps L; Gonzales XF; Levine DA; Langa KM; Garcia N; Khan N; Zahuranec DB; Heeringa SG
    J Alzheimers Dis; 2024; 97(2):649-658. PubMed ID: 38143352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of comorbid depression-diabetes on proteomic outcomes among community-dwelling Mexican Americans with mild cognitive impairment.
    Johnson LA; Zhang F; Large S; Hall J; O'Bryant SE
    Int Psychogeriatr; 2020 Jan; 32(1):17-23. PubMed ID: 31658917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular Depression and Cognition in Mexican Americans.
    Johnson LA; Large SE; Izurieta Munoz H; Hall JR; O'Bryant SE
    Dement Geriatr Cogn Disord; 2019; 47(1-2):68-78. PubMed ID: 30861514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depression is differentially related to cognitive and biomarker outcomes among Mexican Americans.
    O'Bryant SE; Petersen M; Hall J; Johnson LA
    Front Psychiatry; 2022; 13():901403. PubMed ID: 36081458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for mild cognitive impairment among Mexican Americans.
    O'Bryant SE; Johnson L; Reisch J; Edwards M; Hall J; Barber R; Devous MD; Royall D; Singh M
    Alzheimers Dement; 2013 Nov; 9(6):622-631.e1. PubMed ID: 23643456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The link between C-reactive protein and Alzheimer's disease among Mexican Americans.
    O'Bryant SE; Johnson L; Edwards M; Soares H; Devous MD; Ross S; Rohlfing G; Hall J;
    J Alzheimers Dis; 2013; 34(3):701-6. PubMed ID: 23254637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of genetic and health risk factors for mild cognitive impairment and Alzheimer's disease between Hispanic and non-Hispanic white participants.
    Xiao C; Pappas I; Aksman LM; O'Bryant SE; Toga AW;
    Alzheimers Dement; 2023 Nov; 19(11):5086-5094. PubMed ID: 37104247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic Factors Are Related to Brain Amyloid Among Mexican Americans: A HABS-HD Study.
    O'Bryant SE; Petersen M; Hall J; Johnson L;
    J Alzheimers Dis; 2022; 86(4):1745-1750. PubMed ID: 35253763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurodegeneration from the AT(N) framework is different among Mexican Americans compared to non-Hispanic Whites: A Health & Aging Brain among Latino Elders (HABLE) Study.
    O'Bryant SE; Zhang F; Petersen M; Hall J; Johnson LA; Yaffe K; Braskie M; Rissman RA; Vig R; Toga AW;
    Alzheimers Dement (Amst); 2022; 14(1):e12267. PubMed ID: 35155729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validity of the Clinical Dementia Rating Scale Sum of Boxes in Staging and Detection of Cognitive Impairment in Mexican Americans.
    Julayanont P; DeToledo JC
    J Geriatr Psychiatry Neurol; 2022 Jan; 35(1):128-134. PubMed ID: 33261535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterizing plasma NfL in a community-dwelling multi-ethnic cohort: Results from the HABLE study.
    O'Bryant S; Petersen M; Hall J; Johnson L; Yaffe K; Braskie M; Toga AW; Rissman RA;
    Alzheimers Dement; 2022 Feb; 18(2):240-250. PubMed ID: 34310015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The associations between type 2 diabetes and plasma biomarkers of Alzheimer's disease in the Health and Aging Brain Study: Health Disparities (HABS-HD).
    Yu F; Pituch KA; Maxfield M; Baena E; Geda YE; Pruzin JJ; Coon DW; Shaibi GQ;
    PLoS One; 2024; 19(4):e0295749. PubMed ID: 38558059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Effect of the APOE ε2ε4 Genotype on the Development of Alzheimer's Disease (AD) and Mild Cognitive Impairment (MCI) in Non-Latino Whites.
    Ren D; Lopez OL; Lingler JH; Conley Y
    J Am Geriatr Soc; 2020 May; 68(5):1044-1049. PubMed ID: 32017008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Hachinski ischemic scale and cognition: the influence of ethnicity.
    Johnson LA; Cushing B; Rohlfing G; Edwards M; Davenloo H; D'Agostino D; Hall JR; O'Bryant SE
    Age Ageing; 2014 May; 43(3):364-9. PubMed ID: 24321843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.